https://doi.org/10.4081/ejtm.2024.12143
A patient with bilateral neuralgic amyotrophy and hepatitis E virus infection: an educational communication
Submitted: 28 November 2023
Accepted: 28 December 2023
Published: 15 January 2024
Accepted: 28 December 2023
Abstract Views: 413
PDF: 230
HTML: 12
HTML: 12
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Neuralgic Amyotrophy, a peripheral nervous system disorder, is characterized by severe pain and muscle weakness, which can have a significant impact on patients' quality of life. The exact cause of neuralgic amyotrophy is unknown, but it may be linked to immunopathological mechanisms. Recent research has found an association between neuralgic amyotrophy and hepatitis E virus infection. This communication aims to expand knowledge on the clinical phenotype of patients with neuralgic amyotrophy and hepatitis E virus infection, presenting the case of a 55-year-old man diagnosed with bilateral neuralgic amyotrophy and hepatitis E virus infection.
van Alfen N, van Eijk JJ, Ennik T, Flynn SO, Nobacht IE, Groothuis JT, Pillen S, van de Laar FA. Incidence of neuralgic amyotrophy (Parsonage Turner syndrome) in a primary care setting--a prospective cohort study. PLoS One. 2015 May 27;10(5):e0128361. PMID: 26016482; PMCID: PMC4445915.
DOI: https://doi.org/10.1371/journal.pone.0128361
Van Eijk JJ, Groothuis JT, Van Alfen N. Neuralgic amyotrophy: An update on diagnosis, pathophysiology, and treatment. Muscle Nerve. 2016 Mar;53(3):337-50. Epub 2016 Jan 20. PMID: 26662794.
DOI: https://doi.org/10.1002/mus.25008
van Alfen N, van Engelen BG. The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain. 2006 Feb;129(Pt 2):438-50. Epub 2005 Dec 21. PMID: 16371410.
DOI: https://doi.org/10.1093/brain/awh722
Ferrante MA, Wilbourn AJ. Lesion distribution among 281 patients with sporadic neuralgic amyotrophy. Muscle Nerve. 2017 Jun;55(6):858-861. Epub 2017 Feb 3. PMID: 27680713.
DOI: https://doi.org/10.1002/mus.25422
Fong F, Illahi M. Neuralgic amyotrophy associated with hepatitis E virus. Clin Neurol Neurosurg. 2009 Feb;111(2):193-5. Epub 2008 Nov 4. PMID: 18986757.
DOI: https://doi.org/10.1016/j.clineuro.2008.09.005
van Eijk JJ, Madden RG, van der Eijk AA, Hunter JG, Reimerink JH, Bendall RP, Pas SD, Ellis V, van Alfen N, Beynon L, Southwell L, McLean B, Jacobs BC, van Engelen BG, Dalton HR. Neuralgic amyotrophy and hepatitis E virus infection. Neurology. 2014 Feb 11;82(6):498-503. Epub 2014 Jan 8. PMID: 24401685; PMCID: PMC3937863.
DOI: https://doi.org/10.1212/WNL.0000000000000112
Webb GW, Dalton HR. Hepatitis E: an expanding epidemic with a range of complications. Clin Microbiol Infect. 2020 Jul;26(7):828-832. Epub 2020 Apr 3. PMID: 32251845.
DOI: https://doi.org/10.1016/j.cmi.2020.03.039
van Eijk JJJ, Dalton HR, Ripellino P, Madden RG, Jones C, Fritz M, Gobbi C, Melli G, Pasi E, Herrod J, Lissmann RF, Ashraf HH, Abdelrahim M, Masri OABAL, Fraga M, Benninger D, Kuntzer T, Aubert V, Sahli R, Moradpour D, Blasco-Perrin H, Attarian S, Gérolami R, Colson P, Giordani MT, Hartl J, Pischke S, Lin NX, Mclean BN, Bendall RP, Panning M, Peron JM, Kamar N, Izopet J, Jacobs BC, van Alfen N, van Engelen BGM. Clinical phenotype and outcome of hepatitis E virus-associated neuralgic amyotrophy. Neurology. 2017 Aug 29;89(9):909-917. Epub 2017 Aug 2. PMID: 28768846.
DOI: https://doi.org/10.1212/WNL.0000000000004297
Scanvion Q, Perez T, Cassim F, Outteryck O, Lanteri A, Hatron PY, Lambert M, Morell-Dubois S. Neuralgic amyotrophy triggered by hepatitis E virus: a particular phenotype. J Neurol. 2017 Apr;264(4):770-780. Epub 2017 Feb 28. PMID: 28247042.
DOI: https://doi.org/10.1007/s00415-017-8433-z
Garofoli R, Zauderer J, Seror P, Roren A, Guerini H, Rannou F, Drapé JL, Nguyen C, Lefèvre-Colau MM. Neuralgic amyotrophy and hepatitis E infection: 6 prospective case reports. RMD Open. 2020 Nov;6(3):e001401. PMID: 33219125; PMCID: PMC8011528.
DOI: https://doi.org/10.1136/rmdopen-2020-001401
How to Cite
Rojc, B., & Šarabon, N. (2024). A patient with bilateral neuralgic amyotrophy and hepatitis E virus infection: an educational communication. European Journal of Translational Myology, 34(1). https://doi.org/10.4081/ejtm.2024.12143
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.